Connor, Clark & Lunn Investment Management (CC&L)’s MEI Pharma MEIP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,515
Closed -$74K 1348
2022
Q3
$74K Buy
9,515
+5,689
+149% +$44.2K ﹤0.01% 1051
2022
Q2
$46K Buy
+3,826
New +$46K ﹤0.01% 1009
2022
Q1
Sell
-5,984
Closed -$320K 1140
2021
Q4
$320K Sell
5,984
-4,934
-45% -$264K ﹤0.01% 886
2021
Q3
$603K Sell
10,918
-4,432
-29% -$245K ﹤0.01% 733
2021
Q2
$875K Sell
15,350
-3,261
-18% -$186K ﹤0.01% 693
2021
Q1
$1.28M Sell
18,611
-3,842
-17% -$264K 0.01% 651
2020
Q4
$1.19M Buy
22,453
+43
+0.2% +$2.27K 0.01% 602
2020
Q3
$1.4M Buy
22,410
+1,426
+7% +$89K 0.01% 553
2020
Q2
$1.73M Buy
20,984
+8,225
+64% +$679K 0.01% 485
2020
Q1
$411K Buy
12,759
+547
+4% +$17.6K ﹤0.01% 741
2019
Q4
$606K Sell
12,212
-365
-3% -$18.1K ﹤0.01% 635
2019
Q3
$423K Sell
12,577
-935
-7% -$31.4K ﹤0.01% 721
2019
Q2
$676K Sell
13,512
-884
-6% -$44.2K ﹤0.01% 663
2019
Q1
$884K Sell
14,396
-861
-6% -$52.9K 0.01% 551
2018
Q4
$806K Sell
15,257
-2,524
-14% -$133K 0.01% 592
2018
Q3
$1.53M Buy
17,781
+205
+1% +$17.7K 0.01% 488
2018
Q2
$1.39M Sell
17,576
-827
-4% -$65.2K 0.01% 550
2018
Q1
$762K Sell
18,403
-510
-3% -$21.1K ﹤0.01% 514
2017
Q4
$794K Sell
18,913
-1,605
-8% -$67.4K ﹤0.01% 548
2017
Q3
$1.1M Sell
20,518
-245
-1% -$13.1K 0.01% 514
2017
Q2
$992K Buy
20,763
+150
+0.7% +$7.17K 0.01% 501
2017
Q1
$668K Buy
20,613
+454
+2% +$14.7K ﹤0.01% 574
2016
Q4
$581K Sell
20,159
-90
-0.4% -$2.59K ﹤0.01% 571
2016
Q3
$713K Hold
20,249
0.01% 516
2016
Q2
$551K Hold
20,249
﹤0.01% 568
2016
Q1
$510K Hold
20,249
﹤0.01% 564
2015
Q4
$648K Buy
20,249
+3,183
+19% +$102K 0.01% 508
2015
Q3
$536K Buy
17,066
+8,386
+97% +$263K ﹤0.01% 507
2015
Q2
$297K Buy
8,680
+6,515
+301% +$223K ﹤0.01% 497
2015
Q1
$78K Buy
2,165
+1,525
+238% +$54.9K ﹤0.01% 544
2014
Q4
$55K Buy
+640
New +$55K ﹤0.01% 562